The fourth China Bioanalysis Forum Annual Meeting

被引：4
|
作者：
Tang, Daniel [1 ]
Zhong, Dafang [2 ]
Dong, Kelly [3 ]
机构：
[1] United Power PharmaTech, Beijing, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, Pudong Xinqu, Shanghai Shi, Peoples R China
[3] GlaxoSmithKline R&D, Shanghai, Peoples R China
来源：
BIOANALYSIS | 2017年 / 9卷 / 02期
关键词：
bioanalysis conference; CBF; China Bioanalysis Forum;
D O I：
10.4155/bio-2016-4986
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
The fourth China Bioanalysis Forum annual conference, co-organized with the Nanjing International Drug Metabolism Conference, was successfully held in Nanjing, China, between 24-26 June 2016. The theme of the conference was 'how to conduct regulated bioanalysis under China Food and Drug Administration (CFDA) regulations'. In addition, several hot topics including bioanalytical challenges, solutions for biomarkers, antidrug antibody (antibody-drug conjugates) and biologics were discussed. This Conference Report summarizes the major discussion topics from the conference.
引用
收藏
页码：159 / 162
页数：4
相关论文
共 50 条
12345